Bortezomib Accord 1 mg, Pulver zur Herstellung einer lnjektionslösung

7680674810018 CH-67481 Pulver
Bortezomib Accord 1 mg, Pulver zur Herstellung einer lnjektionslösung
Bortezomib Accord 1 mg, Pulver zur Herstellung einer lnjektionslösung
Bortezomib Accord 1 mg, Pulver zur Herstellung einer lnjektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/03/2025
Summary of Product Characteristics
Français
07/03/2025
Summary of Product Characteristics
Italien
07/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 153.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2020

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
67481
Drug name
Bortezomib Accord, Pulver zur Herstellung einer lnjektionslösung
Galenic form
PULPA
ATC Code
L01XG01
Authorization status
Z
Dispensing category
A
First authorization
06/03/2020
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Multiples Myelom

Package details

Description (FR)
BORTEZOMIB Accord subst sèche 1 mg flac
Description (DE)
BORTEZOMIB Accord Trockensub 1 mg Durchstf
Market launch
06/03/2020
Narcotic (BTM)
No

Original drug

Velcade, Lyophilisat zur Herstellung einer Injektionslösung
GTIN: 7680569760015
CHF 460.10
View original

Other package sizes (1)

BORTEZOMIB Accord subst sèche 3.5 mg flac
1 DUR
GTIN: 7680674810025
View